Liaoning He Eye Hospital Group Co., LTD. (SHE:301103)
China · Delayed Price · Currency is CNY 21.45
-0.06 (-0.28%)
At close: Jan 21, 2026
SHE:301103 Revenue
Liaoning He Eye Hospital Group Co., LTD. had revenue of 295.18M CNY in the quarter ending September 30, 2025, with 5.37% growth. This brings the company's revenue in the last twelve months to 1.09B, down -1.80% year-over-year. In the year 2024, Liaoning He Eye Hospital Group Co., LTD. had annual revenue of 1.10B, down -7.56%.
Revenue (ttm)
1.09B
Revenue Growth
-1.80%
P/S Ratio
3.07
Revenue / Employee
331.71K
Employees
3,274
Market Cap
3.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.10B | -89.60M | -7.56% |
| Dec 31, 2023 | 1.19B | 229.92M | 24.07% |
| Jan 1, 2023 | 955.31M | -7.14M | -0.74% |
| Jan 1, 2022 | 962.45M | 123.98M | 14.79% |
| Dec 31, 2020 | 838.47M | 92.91M | 12.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |